• Latest Posts

Sanofi and US Partner Launch Phase III Trial in Hemophilia with RNAi

German Biotech Raises €15M to Treat Heart Failure with Non-coding RNA

Shire sells its RNA platform to a US-based Biotech

RNAi Therapy is Back: Sanofi is firmly on board to treat Hemophilia

CRISPR meets RNAi: a whole new Targeted Therapy

Genfit’s Non-Invasive Diagnostic could unlock the NASH Market


“This 30M Series A will help us bring RNA Therapeutics to Immuno-Oncology”

RNA therapy starts first-of-a-kind trial to treat Liver Cancer

Irish Gene Therapy for Blindness is Acquired by US Leader in the Field

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Amaroq Therapeutics ‘hits early milestones’ in cancer treatment